SOPHiA GENETICS SA Sales And Marketing Expense
SOPHiA GENETICS SA (SOPH) reported Sales And Marketing Expense of $36.12 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-03.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SalesAndMarketingExpense · last filed 2026-03-03
- SOPHiA GENETICS SA sales and marketing expense for the quarter ending 2025-06-30 was $10.03M, a 38.25% increase year-over-year.
- SOPHiA GENETICS SA sales and marketing expense for the quarter ending 2024-06-30 was $7.26M, a 0.76% increase year-over-year.
- SOPHiA GENETICS SA sales and marketing expense for the quarter ending 2023-06-30 was $7.20M, a 12.53% decline year-over-year.
- SOPHiA GENETICS SA sales and marketing expense for the quarter ending 2022-06-30 was $8.23M.
| Period end | Sales And Marketing Expense 3 month | Sales And Marketing Expense 6 month | Sales And Marketing Expense 12 month |
|---|---|---|---|
| 2025-12-31 | $36.12M 20-F · filed 2026-03-03 | ||
| 2025-06-30 | $10.03M 6-K · filed 2025-08-05 | $17.57M 6-K · filed 2025-08-05 | |
| 2024-12-31 | $29.37M 20-F · filed 2026-03-03 | ||
| 2024-06-30 | $7.26M 6-K · filed 2025-08-05 | $14.21M 6-K · filed 2025-08-05 | |
| 2023-12-31 | $28.42M 20-F · filed 2026-03-03 | ||
| 2023-06-30 | $7.20M 6-K · filed 2024-08-06 | $13.63M 6-K · filed 2024-08-06 | |
| 2022-12-31 | $28.27M 20-F · filed 2025-03-04 | ||
| 2022-06-30 | $8.23M 6-K · filed 2023-08-08 | $16.10M 6-K · filed 2023-08-08 | |
| 2021-12-31 | $28.73M 20-F · filed 2024-03-05 | ||
| 2020-12-31 | $17.43M 20-F · filed 2023-03-07 | ||
| 2019-12-31 | $19.41M 20-F · filed 2022-03-15 |